ArticleJournal of translational medicine2023

Targeting FGFRs by pemigatinib induces G1 phase cell cycle arrest, cellular stress and upregulation of tumor suppressor microRNAs.

Angelica Pace et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.